Orchid Chemicals to sell portion of its businesses to Hospira Healthcare

18 Mar 2014 Evaluate

Orchid Chemicals and Pharmaceuticals has received Corporate Debt Restructuring (CDR) approval, paving the way for the sale of a portion of its businesses to Hospira Healthcare India, and cut debt.

The company will be repaying a portion of the debt (i.e Rs 681 crore) to the lenders with proceeds from the sale, while the remaining Rs 2,866 crore will be restructured.

The CDR scheme also includes funding to meet working capital borrowings. The restructured debt, along with funded loans, will have to be repaid in eight years.

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Share Price

790.00 30.85 (4.06%)
01-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1726.80
Dr. Reddys Lab 1252.40
Cipla 1500.00
Zydus Lifesciences 914.55
Lupin 2106.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×